EpiCypher, Inc. attended and presented at the UNC Emerging Multi-Omic Technology Symposium highlighting sequencing, spatial technologies, and multi-omic approaches.
Published
Signal category
Presence & Recognition
Quote
“EpiCypher attended and presented at the UNC Emerging Multi-Omic Technology Symposium”
— EpiCypher, Inc. team
Company
EpiCypher, Inc.
Empowering Epigenomic Research with Cutting-Edge Tools and Services
- Industry
- Biotechnology Research
- Location
- Durham, US
- Company size
- 49 employees
A pioneer in the field of epigenetics and chromatin biology, EpiCypher is a bioscience company developing transformative technologies and delivering superior products to researchers world-wide. Our technologies and products are making studies possible that were not imaginable just a few years ago. Our renowned chromatin researchers possess expertise and unique insight into chromatin biology and drug discovery that benefit our customers in ways other companies cannot. Epigenetics, the study of changes in heritable traits that occur independent of alterations in changes in the underlying DNA sequence, is an emerging and important area of biomedical research with broad impact on human health and disease.
Founded 2012